Sodium stearate
Suppliers
Names
[ CAS No. ]:
822-16-2
[ Name ]:
Sodium stearate
[Synonym ]:
sodium,octadecanoate
Octadecanoic acid, sodium salt (1:1)
Octadecanoic acid sodium salt
octadecanoic acid, sodium salt
Sodium stearate
SODIUM OCTADECANOATE
EINECS 212-490-5
Stearic Acid, Sodium Salt
stearic acid sodium salt
MFCD00036404
Chemical & Physical Properties
[ Density]:
1.103 g/cm3
[ Boiling Point ]:
359.4ºC at 760 mmHg
[ Melting Point ]:
245 - 255ºC
[ Molecular Formula ]:
C18H35NaO2
[ Molecular Weight ]:
306.459
[ Flash Point ]:
162.4ºC
[ Exact Mass ]:
306.253479
[ PSA ]:
40.13000
[ LogP ]:
4.99780
[ Storage condition ]:
2-8°C
[ Stability ]:
Stable. Incompatible with strong oxidizing agents.
[ Water Solubility ]:
SOLUBLE IN COLD AND HOT WATER
MSDS
Toxicological Information
CHEMICAL IDENTIFICATION
- RTECS NUMBER :
- WI4725000
- CHEMICAL NAME :
- Stearic acid, sodium salt
- CAS REGISTRY NUMBER :
- 822-16-2
- LAST UPDATED :
- 199712
- DATA ITEMS CITED :
- 8
- MOLECULAR FORMULA :
- C18-H35-O2.Na
- MOLECULAR WEIGHT :
- 306.52
- WISWESSER LINE NOTATION :
- QV17 &-NA-
HEALTH HAZARD DATA
ACUTE TOXICITY DATA
- TYPE OF TEST :
- LDLo - Lowest published lethal dose
- ROUTE OF EXPOSURE :
- Unreported
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 400 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- ATMPA2 Annals of Tropical Medicine and Parasitology. (Grune & Stratton, Inc., POB 6280, Duluth, MN 55806) V.1- 1907- Volume(issue)/page/year: 32,177,1938
- TYPE OF TEST :
- LDLo - Lowest published lethal dose
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Mammal - dog
- DOSE/DURATION :
- 10 mg/kg
- TOXIC EFFECTS :
- Vascular - thrombosis distant from injection site
- REFERENCE :
- JCINAO Journal of Clinical Investigation. (Rockefeller Univ. Press, 1230 York Ave., New York, NY 10021) V.1- 1924- Volume(issue)/page/year: 42,860,1963 *** REVIEWS *** ACGIH TLV-Not classifiable as a human carcinogen DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: TLV/BEI,1997 ACGIH TLV-TWA 10 mg/m3 DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: TLV/BEI,1997 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - 69445 No. of Facilities: 8011 (estimated) No. of Industries: 75 No. of Occupations: 89 No. of Employees: 98215 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - 69445 No. of Facilities: 6021 (estimated) No. of Industries: 60 No. of Occupations: 54 No. of Employees: 98046 (estimated) No. of Female Employees: 35115 (estimated)
Safety Information
[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
[ Hazard Codes ]:
Xn
[ Safety Phrases ]:
S24/25
[ RIDADR ]:
UN 3077 9/PG 3
[ WGK Germany ]:
1
[ RTECS ]:
WI4725000
[ HS Code ]:
2915709000
Synthetic Route
Precursor & DownStream
Precursor
DownStream
Customs
[ HS Code ]: 2915709000
[ Summary ]:
2915709000. palmitic acid and its salts and esters. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:5.5%. General tariff:30.0%
Articles
J. Pharm. Sci. 103(7) , 2157-65, (2014)
The major obstacle to glioblastoma pharmacological therapy is the overcoming of the blood-brain barrier (BBB). In literature, several strategies have been proposed to overcome the BBB: in this experim...
Int. J. Pharm. 486 , 232-41, (2015)
Intravenous injections of propofol emulsions are accompanied by pain likely due to the interaction of the dissolved drug with endothelial cells of the vasculature. It is commonly hypothesized that red...
Biomater. Sci. 3 , 861-9, (2015)
In order for patients to avail of the therapeutic benefits of antioxidant drugs efficiently and conveniently, a robust oral delivery system needs to be developed. However, a common problem in oral dru...